Position in LH
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$2,145,360
-$32,610 QoQ
Shares Held
7,662
-6.1% QoQ
Ownership
0.009%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#364
of 1,044 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 55%
Shared 0%
None 45%
Common Shares in LH Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Dana Investment Advisors, Inc. holds $39,876,531 across 6 Diagnostics & Research names. LH ranks #3 (5.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IQV |
Iqvia Holdings Inc.
|
165,955 | $32,065,825 | |
| 2 | TMO |
Thermo Fisher Scientific Inc.
|
8,107 | $4,064,525 | |
| 3 | LH |
Labcorp Holdings Inc.
This page
|
7,662 | $2,145,360 | |
| 4 | DHR |
Danaher Corp /De/
|
3,888 | $740,586 | |
| 5 | IDXX |
Idexx Laboratories Inc /De
|
980 | $515,911 | |
| 6 | NEO |
Neogenomics Inc
|
23,600 | $344,324 |
All Filings in LH
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,145,360 | 7,662 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $2,177,970 | 8,163 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $2,066,498 | 8,237 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $2,371,115 | 8,260 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $2,233,172 | 8,507 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $1,995,745 | 8,575 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $1,990,038 | 8,678 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $2,164,180 | 9,684 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $1,984,018 | 9,749 | Shares | Sole | 2024-08-27 | |
| No filing history on record for this holder in this stock. | ||||||